Evaluation of early-phase [(18)F]-florbetaben PET acquisition in clinical routine cases

OBJECTIVES: In recent years several [(18)F]-labelled amyloid PET tracers have been developed and have obtained clinical approval. There is accumulating evidence that early (post injection) acquisitions with these tracers are equally informative as conventional blood flow and metabolism studies for d...

Descripción completa

Detalles Bibliográficos
Autores principales: Daerr, Sonja, Brendel, Matthias, Zach, Christian, Mille, Erik, Schilling, Dorothee, Zacherl, Mathias Johannes, Bürger, Katharina, Danek, Adrian, Pogarell, Oliver, Schildan, Andreas, Patt, Marianne, Barthel, Henryk, Sabri, Osama, Bartenstein, Peter, Rominger, Axel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5257027/
https://www.ncbi.nlm.nih.gov/pubmed/28138429
http://dx.doi.org/10.1016/j.nicl.2016.10.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5257027/
https://www.ncbi.nlm.nih.gov/pubmed/28138429
http://dx.doi.org/10.1016/j.nicl.2016.10.005

Ejemplares similares